Literature DB >> 31366688

Introduction to Measurement of Avidity of Anti-Coxiella burnetii IgG in Diagnosis of Q Fever.

Léa Luciani1, Coralie L'Ollivier1,2, Matthieu Million1,3, Bernard Amphoux1, Sophie Edouard1,3, Didier Raoult4,3.   

Abstract

Due to the atypical serological profile of some patients with primary Q fever infection who do not develop IgM against Coxiella burnetii, we developed an avidity test to distinguish recent or past infections. We tested 39 serum samples by immunofluorescence with conventional assay and after urea treatment from 26 patients at different stages of the disease. We observed a strong avidity in the 15 serum samples from patients with infections of >6 months and a low avidity for sera from patients with recent infections. A complete denaturation of the antibody-antigen complex was observed for patients for whom the time since the beginning of infection was <1 month and a mean of 2.06 ± 0.54 lowered titers when the infection was less than 3 months old. That was statistically significant compared to sera from patients with infections of greater than 6 months (mean 0.20 ± 0.41) and with infections between 3 and 6 months (mean, 1.17 ± 0.41) (P = 0.0022 and P < 0.0001, respectively). These results were visualized by Western blotting. We concluded that high avidity (≤1 lowered titer) ruled out infection during the last 6 months and that complete denaturation was related to an infection which had occurred within the previous 3 months. Between these two situations, the avidity test is inconclusive. We suggest using an avidity test for atypical Q fever serology that could be misclassified as residual antibodies (IgG against C. burnetii detected without active or recent infection) and for pregnant women risking obstetrical complications. This new test will dramatically improve the diagnosis and management of patients with Q fever.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Coxiella burnetiizzm321990; IgG; Q fever; avidity; datation; diagnosis; immunofluorescence; serology

Year:  2019        PMID: 31366688      PMCID: PMC6760940          DOI: 10.1128/JCM.00539-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Comparison of PCR and serology assays for early diagnosis of acute Q fever.

Authors:  Pierre-Edouard Fournier; Didier Raoult
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak.

Authors:  Hervé Tissot-Dupont; Véronique Vaillant; Sylvie Rey; Didier Raoult
Journal:  Clin Infect Dis       Date:  2006-12-06       Impact factor: 9.079

3.  Coxiella burnetii DNA, but not viable bacteria, in dairy products in France.

Authors:  Carole Eldin; Emmanouil Angelakis; Aurélie Renvoisé; Didier Raoult
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

4.  Q fever during pregnancy: diagnosis, treatment, and follow-up.

Authors:  Didier Raoult; Florence Fenollar; Andreas Stein
Journal:  Arch Intern Med       Date:  2002-03-25

5.  Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment.

Authors:  Matthieu Million; Gaëlle Walter; Franck Thuny; Gilbert Habib; Didier Raoult
Journal:  Clin Infect Dis       Date:  2013-06-20       Impact factor: 9.079

6.  Long-term outcome of Q fever endocarditis: a 26-year personal survey.

Authors:  Matthieu Million; Franck Thuny; Hervé Richet; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2010-07-14       Impact factor: 25.071

Review 7.  Recent advances in the study of Q fever epidemiology, diagnosis and management.

Authors:  Matthieu Million; Didier Raoult
Journal:  J Infect       Date:  2015-04-24       Impact factor: 6.072

8.  Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.

Authors:  N K Blackburn; T G Besselaar; B D Schoub; K F O'Connell
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

Review 9.  Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity.

Authors:  Maija Lappalainen; Klaus Hedman
Journal:  Ann Ist Super Sanita       Date:  2004       Impact factor: 1.663

10.  Reevaluation of the risk of fetal death and malformation after Q Fever.

Authors:  Matthieu Million; France Roblot; Dominiques Carles; Felicetta D'Amato; Camelia Protopopescu; Maria Patrizia Carrieri; Didier Raoult
Journal:  Clin Infect Dis       Date:  2014-04-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.